Drug archive
Rotavirus Vaccine Live Oral (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Immunizing agent (active)
Description
Rotavirus (ROE-ta VYE-rus) vaccine live oral is an immunizing agent used to prevent infection by the rotavirus. It works by causing your body to produce its own protection (antibodies) against the virus.
Rotavirus infection is the single most important cause of diarrhea and vomiting in infants and young children both in developed and developing countries. If untreated, severe rotaviral diarrhea in infants can rapidly become life-threatening. The risk of serious complications and death from rotaviral infection is greater for infants and younger children than for adults.
Immunization against rotavirus infection is recommended for infants 2 to 6 months of age. The first dose of rotavirus vaccine live oral may be administered at as early as 6 weeks of age.
This vaccine is to be administered only by or under the supervision of your doctor or other health care professional.
The medicine was withdrawn from the U.S. market in October 1999.